References
1) Deacock, S. (2008). An approach to the patient with urticaria. Clinical & Experimental Immunology, 153(2), pp.151-161.
2) Fröhlich, E. and Wahl, R. (2017). Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases. Frontiers in Immunology, 8.
3) Kravets, I. (2016). Hyperthyroidism: Diagnosis and Treatment. American Family Physician, 93(5), pp.1-2.
4) Isaacs, N. and Ertel, N. (1971). Urticaria and pruritus: Uncommon manifestations of hyperthyroidism. Journal of Allergy and Clinical Immunology, 48(2), pp.73-81.
5) Lee, S., Ha, E., Jee, H., Lee, K., Lee, S., Kim, M., Kim, D., Jung, Y., Sheen, Y., Sung, M. and Han, M. (2017). Prevalence and Risk Factors of Urticaria With a Focus on Chronic Urticaria in Children. Allergy, Asthma & Immunology Research, 9(3), p.212.
6) O’Donnell, B., Lawlor, F., Simpson, J., Morgan, M. and Greaves, M. (1997). The impact of chronic urticaria on the quality of life. British Journal of Dermatology, 136(2), pp.197-201.
7) Baiardini, I., Pasquali, M., Braido, F., Fumagalli, F., Guerra, L., Compalati, E., Braga, M., Lombardi, C., Fassio, O. and Canonica, G. (2005). A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-Q2oL). Allergy, 60(8), pp.1073-1078.
8) Cks.nice.org.uk. (2019). Urticaria - NICE CKS. [online] Available at: https://cks.nice.org.uk/urticaria#!scenario [Accessed 20 Jul. 2019].
9) Rothfeld, B. (1968). Pruritus as a Symptom in Hyperthyroidism. JAMA: The Journal of the American Medical Association, 205(1), p.52.
10) Selvendran, S. and Aggarwal, N. (2018). Chronic urticaria and thyroid autoimmunity: a perplexing association. Oxford Medical Case Reports, 2018(2).
11) Altrichter, S., Peter, H., Pisarevskaja, D., Metz, M., Martus, P. and Maurer, M. (2011). IgE Mediated Autoallergy against Thyroid Peroxidase – A Novel Pathomechanism of Chronic Spontaneous Urticaria?. PLoS ONE, 6(4), p.e14794.
12) Metz, M., Staubach, P., Bauer, A., Brehler, R., Gericke, J., Kangas, M., Ashton-Chess, J., Jarvis, P., Georgiou, P., Canvin, J., Hillenbrand, R., Erpenbeck, V. and Maurer, M. (2017). Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin. Theranostics, 7(5), pp.1266-1276.
13) Abraham, P. and Acharya (2009). Current and emerging treatment options for Graves’ hyperthyroidism. Therapeutics and Clinical Risk Management, p.29.
14) Brent, G. (2012). Mechanisms of thyroid hormone action. Journal of Clinical Investigation, 122(9), pp.3035-3043.
15) Ponmani, C., Mcclatchey, M., Kanzaria, S., Keane, M. and Banerjee, K. (2014). Severe Urticaria in Graves’ Disease: is Carbimazole to Blame?. Hormone Research in Paediatrics, [online] 82(P-D-2-2-599). Available at: http://abstracts.eurospe.org/hrp/0082/hrp0082p2-d2-599 [Accessed 20 Jul. 2019].
16) Pan, S., Wood, D. and Chatterjee, K. (2012). Fixed drug eruption in the endocrine clinic: rare presentation of reaction to carbimazole. Endocrine Abstracts, [online] 28(P367). Available at: https://www.endocrine-abstracts.org/ea/0028/ea0028p367 [Accessed 20 Jul. 2019].
17) Pearce, S. (2004). Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clinical Endocrinology, 61(5), pp.589-594.
18) Demir, M., Yaylaci, S., Tamer, A. and Ayturk, S. (2013). Propylthiouracil induced leukocytoclastic vasculitis: A rare manifestation. Indian Journal of Endocrinology and Metabolism, 17(2), p.339.
19) Talapatra, I., Prabhakar, K. and Tymms, D. (2007). Urticaria; An Uncommon Presentation Of Thyrotoxicosis. European Journal of General Medicine, 4(4), pp.205-208.